Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$645M |
| 2 |
T-Mobile US
TMUS
|
+$640M |
| 3 |
AT&T
T
|
+$517M |
| 4 |
Humana
HUM
|
+$481M |
| 5 |
Boston Scientific
BSX
|
+$400M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$1.24B |
| 2 |
Apple
AAPL
|
+$755M |
| 3 |
Meta Platforms (Facebook)
META
|
+$707M |
| 4 |
Caterpillar
CAT
|
+$472M |
| 5 |
Advanced Micro Devices
AMD
|
+$449M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.33% |
| 2 | Technology | 3.2% |
| 3 | Financials | 2.22% |
| 4 | Industrials | 2.17% |
| 5 | Consumer Discretionary | 2.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NGD
11726
CALL
DELISTED
New Gold Inc
NGD
| $65.5K | ﹤0.01% |
59,500
-47,800
| -45% | -$48.7K |
|
|
XHR
11727
CALL
Xenia Hotels & Resorts
XHR
$1.77B
| $65.5K | ﹤0.01% |
5,000
+4,400
| +733% | +$60.8K |
|
11728
PUT
Nautilus Biotechnolgy
NAUT
$114M
| $65.4K | ﹤0.01% |
+23,600
| New | +$49.5K |
|
|
BFX
11729
DELISTED
BowFlex Inc.
BFX
| $65.4K | ﹤0.01% |
+48,781
| New | +$80.6K |
|
11730
indie Semiconductor
INDI
$995M
| $65.2K | ﹤0.01% |
6,181
-458,810
| -99% | -$4.1M |
|
11731
Veru
VERU
$46.5M
| $65.2K | ﹤0.01% |
5,618
-63,429
| -92% | -$2.57M |
|
11732
NetSol Technologies
NTWK
$48.3M
| $65K | ﹤0.01% |
24,605
+16,373
| +199% | +$46K |
|
|
ACRO.WS
11733
DELISTED
Acropolis Infrastructure Acquisition Corp Warrants
ACRO.WS
| $64.8K | ﹤0.01% |
379,221
-459,783
| -55% | -$79.6K |
|
|
NAK
11734
Northern Dynasty Minerals
NAK
$908M
| $64.8K | ﹤0.01% |
271,370
-303,123
| -53% | -$69.8K |
|
|
PRPH
11735
CALL
DELISTED
ProPhase Labs
PRPH
| $64.8K | ﹤0.01% |
850
-20
| -2% | -$1.61K |
|
11736
Candel Therapeutics
CADL
$897M
| $64.6K | ﹤0.01% |
+47,174
| New | +$92K |
|
11737
DiaMedica Therapeutics
DMAC
$360M
| $64.6K | ﹤0.01% |
42,234
+3,018
| +8% | +$4.79K |
|
11738
PUT
Pebblebrook Hotel Trust
PEB
$2.06B
| $64.6K | ﹤0.01% |
4,600
-29,600
| -87% | -$432K |
|
11739
PUT
Cato Corp
CATO
$67.9M
| $64.5K | ﹤0.01% |
7,300
-2,300
| -24% | -$21.7K |
|
11740
CALL
First Trust Health Care AlphaDEX Fund
FXH
$1.11B
| $64.5K | ﹤0.01% |
600
-4,000
| -87% | -$435K |
|
11741
PUT
New Mountain Finance
NMFC
$730M
| $64.5K | ﹤0.01% |
5,300
+3,500
| +194% | +$44K |
|
|
SPTN
11742
PUT
DELISTED
SpartanNash
SPTN
| $64.5K | ﹤0.01% |
2,600
+1,500
| +136% | +$43.2K |
|
11743
PUT
Hayward Holdings
HAYW
$3.22B
| $64.5K | ﹤0.01% |
5,500
+400
| +8% | +$4.9K |
|
11744
CALL
Silgan Holdings
SLGN
$4.49B
| $64.4K | ﹤0.01% |
1,200
-1,400
| -54% | -$73.8K |
|
11745
PUT
Victory Capital Holdings
VCTR
$7.27B
| $64.4K | ﹤0.01% |
2,200
-600
| -21% | -$18.3K |
|
|
ACHL
11746
DELISTED
Achilles Therapeutics
ACHL
| $64.4K | ﹤0.01% |
67,246
+42,252
| +169% | +$45.8K |
|
11747
Intellicheck
IDN
$56.9M
| $64.4K | ﹤0.01% |
25,750
+23,787
| +1,212% | +$58.6K |
|
11748
PUT
Suburban Propane Partners
SPH
$1.18B
| $64.3K | ﹤0.01% |
4,200
-2,800
| -40% | -$43.3K |
|
|
PPBT
11749
CALL
Purple Biotech
PPBT
$2.44M
| $64.2K | ﹤0.01% |
183
-146
| -44% | -$54.7K |
|
11750
CALL
Nektar Therapeutics
NKTR
$2.49B
| $64.2K | ﹤0.01% |
6,087
+5,374
| +754% | +$163K |
|
Similar funds
Ken Griffin's Q1 2023 Portfolio in Review
As of Q1 2023, Ken Griffin held 16,292 positions worth $455B, up 6.2% from $428B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Ken Griffin withdrew a net $26.7B in Q1 2023, closing 1,652 positions and reducing 6,687 holdings. Its most notable exit was Restaurant Brands International, an estimated $93.3M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 3.3% of assets, up from 2.9% a quarter earlier, followed by Technology and Financials.
Against the trend, Ken Griffin opened a new position in Keurig Dr Pepper worth $238M.
- Ken Griffin's largest Q1 2023 buy was Keurig Dr Pepper: 6,751,572 shares worth $238M.
- Ken Griffin added most to Invesco QQQ Trust in Q1 2023, an estimated $645M increase.
- Ken Griffin's biggest Q1 2023 reduction was Tesla, cutting an estimated $1.24B.
- Ken Griffin fully exited Restaurant Brands International in Q1 2023, selling an estimated $93.3M.
- Ken Griffin's ten largest holdings make up 33% of its $455B portfolio in Q1 2023.
- Ken Griffin opened 1,466 new positions and closed 1,652 in Q1 2023.
- Ken Griffin's portfolio value rose 6.2% quarter-over-quarter to $455B.
Based on Citadel Advisors's 13F filing for Q1 2023, filed 15 May 2023.